Authors:
De Jong, D
Van Hooren, EG
Macklon, NS
Mannaerts, BMJL
Fauser, BCJM
Citation: D. De Jong et al., Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using aGnRH antagonist (orgalutran/antagon) to prevent a premature LH surge: A case report, J AS REPROD, 18(1), 2001, pp. 30-33
Citation: Ns. Macklon et Bcjm. Fauser, Differential dose of antagonist (Ganirelix) relative to exogenous FSH - Reply, FERT STERIL, 76(5), 2001, pp. 1080-1080
Authors:
de Jong, D
Macklon, NS
Eijkemans, MJC
Mannaerts, BMJL
Bennink, HJTC
Fauser, BCJM
Citation: D. De Jong et al., Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon), FERT STERIL, 75(4), 2001, pp. 688-693
Citation: Ns. Macklon et Bcjm. Fauser, Regulation of follicle development and novel approaches to ovarian stimulation for IVF, HUM REP UPD, 6(4), 2000, pp. 307-312
Citation: D. De Jong et al., A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with thegonadotropin-releasing hormone antagonist cetrorelix, FERT STERIL, 73(5), 2000, pp. 1051-1054
Authors:
Macklon, NS
Laudy, JAM
Mulder, PGH
Wladimiroff, JW
Citation: Ns. Macklon et al., Behavior-state-dependent changes in human fetal pulmonary blood flow velocity waveforms, OBSTET GYN, 93(2), 1999, pp. 184-188